Aggressive therapy improves cirrhosis in glycogen storage disease type IX

Mol Genet Metab. 2013 Jun;109(2):179-82. doi: 10.1016/j.ymgme.2013.03.009. Epub 2013 Mar 21.

Abstract

Glycogen storage disease type IX (GSD IX) is described as a benign condition that often does not require treatment. Most patients with the disease are thought to outgrow the childhood manifestations, which include hepatomegaly, poor growth, and ketosis with or without hypoglycemia. Long term complications including fibrosis and cirrhosis have seldom been reported in the most common subtype, GSD IXα. We present two cases of children with GSD IXα who had fibrosis at the time of diagnosis in addition to the commonly reported disease manifestations. Structured therapy with frequent doses of uncooked cornstarch and protein supplementation was initiated, and both children responded with improved growth velocity, increased energy, decreased hepatomegaly and improved well-being. Additionally, radiographic features of fibrosis improved. We propose that GSD IXα is not a benign condition. Even in patients with a less severe presentation, consideration of a structured treatment regimen to improve quality of life appears warranted.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Child
  • Dietary Proteins / administration & dosage*
  • Glycogen Storage Disease / diagnosis
  • Glycogen Storage Disease / diet therapy
  • Humans
  • Male
  • Starch / administration & dosage*
  • Treatment Outcome

Substances

  • Dietary Proteins
  • Starch

Supplementary concepts

  • Glycogen Storage Disease Type Ix